An in silico framework for integrating epidemiologic and genetic evidence with health care applications: ventilation-related pneumothorax as a case illustration
Conclusion Integration of complementary genetic evidence into epidemiologic analysis can lead to a cost- and time-efficient discovery of the risk predictors and markers and thus can facilitate more efficient marker-based evaluation of medical product performance.
Source: Journal of the American Medical Informatics Association - Category: Information Technology Authors: Torosyan, Y., Hu, Y., Hoffman, S., Luo, Q., Carleton, B., Marinac-Dabic, D. Tags: Research and Applications Source Type: research
More News: Biotechnology | Databases & Libraries | Epidemiology | Genetics | Health | Health Management | Information Technology | Pneumothorax